|
已读[208]
发布: 2014/12/18 05:07:02
Pharmacy Practice News CANTATA-SU, a randomized, double-blind, Phase III trial, included 1,450 patients with type 2 DM, who received metformin with once-daily canagliflozin 100 or 300 mg, or with glimepiride, a long-acting sulfonylurea anti-diabetic drug (Lancet 2013 ...
|
|
|
已读[223]
发布: 2014/12/18 05:06:57
Healio Ulrik M. Mogensen, MD, of the department of cardiology at University Hospital Rigshospitalet in Denmark, and colleagues evaluated 11,081 patients receiving sulfonylurea with insulin and 16,910 patients receiving metformin with insulin to determine the ... and more »
|
|
|
已读[201]
发布: 2014/12/10 08:39:19
Medical Xpress The Federal Joint Committee (G-BA) specified different appropriate comparator therapies for the subindications, resulting in a total of five comparisons: empagliflozin as monotherapy versus a sulfonylurea (A), in combination with metformin versus ... and more »
|
|
|
已读[202]
发布: 2014/12/10 08:39:02
News-Medical.net The Federal Joint Committee (G-BA) specified different appropriate comparator therapies for the subindications, resulting in a total of five comparisons...
|
|
|
已读[209]
发布: 2014/12/10 08:38:46
Medscape They defined all periods of exposure to thiazolidinediones, as well as to metformin, insulin, and sulfonylurea for each patient. Out of this cohort, they identified 3248 cases of incident bladder cancer, 117 of which occurred among subjects who had ... and more »
|
|
|
已读[208]
发布: 2014/12/10 08:38:30
The Pharmaceutical Journal Joanna is a freelance medical writer with a BSc (Hons) in Medical Science & Pharmacology and 15 years' experience working in the field of medical communications. Journalistic work includes clinical research summaries, interviews, feature articles and ...
|
|
|
已读[216]
发布: 2014/12/10 08:38:13
AJMC.com Managed Markets Network Study Design: Patients with T2DM who were treated with saxagliptin (N = 13,929), sulfonylurea (N = 117,756), or sitagliptin (N = 36,813) in 2010 or later were identified in a database of commercially insured beneficiaries. Patients were required to ...
|
|
|
已读[205]
发布: 2014/12/10 08:37:59
Diabetes In Control This study examined the efficacy of saxagliptin when used in combination therapy with metformin, a sulfonylurea , a thiazolidinedione or insulin. It also examined saxagliptin's use in triple therapy with metformin and a sulfonylurea . Separate randomized ...
|
|
|
已读[202]
发布: 2014/12/10 08:37:41
Medscape Participants included 15,516 patients who were not previously treated for diabetes, in whom therapy with metformin, a sulfonylurea (SU), a thiazolidinedione (TZD), or a dipeptidyl peptidase 4-inihibitor (DPP4) was initiated. The primary outcome was ...
|
|
|
已读[223]
发布: 2014/12/10 08:37:23
Diabetes News Journal Sulfonylurea , DPP-4 inhibitor, and GLP-1 agonist are being tested in the stud, all of which increase insulin levels directly or indirectly. A long-acting insulin medication will also be tested. Dr. Hollander concluded: “I think it's a study that's ... and more »
|
|
« 上一页 |
查看结果81-90共686
|
下一页 »
|
|